1
|
Zhu YY, Niu Y, Niu YN, Yang SD. Recent advances in the synthesis and applications of phosphoramides. Org Biomol Chem 2021; 19:10296-10313. [PMID: 34812834 DOI: 10.1039/d1ob01566d] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Phosphoramide, as an important framework of many biologically active molecules, has attracted widespread attention in recent decades. It is not only widely used in pharmaceuticals because of its excellent biological activities, but it also shows good performance in organic dyes, flame retardants and extractors. Thus, it is of great significance to develop effective and convenient methods for the synthesis of phosphoramides. In this review, the recent advancements made in the synthesis routes and applications of phosphoramides are discussed. The synthetic strategies of phosphoramides can be separated into five categories: phosphorus halides as the substrate, phosphates as the substrate, phosphorus hydrogen as the substrate, azides as the substrate and other methods. The latest examples of these methods are provided and some representative mechanisms are also described.
Collapse
Affiliation(s)
- Yuan-Yuan Zhu
- State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China.
| | - Yuan Niu
- State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China.
| | - Yan-Ning Niu
- Department of Teaching and Research, Nanjing Forestry University, Huaian 223003, P. R. China
| | - Shang-Dong Yang
- State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou 730000, China.
| |
Collapse
|
4
|
Petkowski JJ, Bains W, Seager S. Natural Products Containing a Nitrogen-Sulfur Bond. JOURNAL OF NATURAL PRODUCTS 2018; 81:423-446. [PMID: 29364663 DOI: 10.1021/acs.jnatprod.7b00921] [Citation(s) in RCA: 93] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Only about 100 natural products are known to contain a nitrogen-sulfur (N-S) bond. This review thoroughly categorizes N-S bond-containing compounds by structural class. Information on biological source, biological activity, and biosynthesis is included, if known. We also review the role of N-S bond functional groups as post-translational modifications of amino acids in proteins and peptides, emphasizing their role in the metabolism of the cell.
Collapse
Affiliation(s)
- Janusz J Petkowski
- Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
| | - William Bains
- Rufus Scientific , 37 The Moor, Melbourn, Royston, Herts SG8 6ED, U.K
| | - Sara Seager
- Department of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
- Department of Physics, Massachusetts Institute of Technology , 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
5
|
Guasch L, Ojeda MJ, González-Abuín N, Sala E, Cereto-Massagué A, Mulero M, Valls C, Pinent M, Ardévol A, Garcia-Vallvé S, Pujadas G. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. PLoS One 2012; 7:e44971. [PMID: 22984596 PMCID: PMC3440348 DOI: 10.1371/journal.pone.0044971] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2011] [Accepted: 08/16/2012] [Indexed: 12/13/2022] Open
Abstract
Background There has been great interest in determining whether natural products show biological activity toward protein targets of pharmacological relevance. One target of particular interest is DPP-IV whose most important substrates are incretins that, among other beneficial effects, stimulates insulin biosynthesis and secretion. Incretins have very short half-lives because of their rapid degradation by DPP-IV and, therefore, inhibiting this enzyme improves glucose homeostasis. As a result, DPP-IV inhibitors are of considerable interest to the pharmaceutical industry. The main goals of this study were (a) to develop a virtual screening process to identify potential DPP-IV inhibitors of natural origin; (b) to evaluate the reliability of our virtual-screening protocol by experimentally testing the in vitro activity of selected natural-product hits; and (c) to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV binding site. Methodology/Principal Findings We predicted that 446 out of the 89,165 molecules present in the natural products subset of the ZINC database would inhibit DPP-IV with good ADMET properties. Notably, when these 446 molecules were merged with 2,342 known DPP-IV inhibitors and the resulting set was classified into 50 clusters according to chemical similarity, there were 12 clusters that contained only natural products for which no DPP-IV inhibitory activity has been previously reported. Nine molecules from 7 of these 12 clusters were then selected for in vitro activity testing and 7 out of the 9 molecules were shown to inhibit DPP-IV (where the remaining two molecules could not be solubilized, preventing the evaluation of their DPP-IV inhibitory activity). Then, the hit with the highest activity was used as a lead compound in the prediction of more potent derivatives. Conclusions/Significance We have demonstrated that our virtual-screening protocol was successful in identifying novel lead compounds for developing more potent DPP-IV inhibitors.
Collapse
Affiliation(s)
- Laura Guasch
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Maria José Ojeda
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Noemí González-Abuín
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Esther Sala
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Adrià Cereto-Massagué
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Miquel Mulero
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Cristina Valls
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Montserrat Pinent
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Anna Ardévol
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
| | - Santiago Garcia-Vallvé
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
- Centre Tecnològic de Nutrició i Salut, TECNIO, Campus of International excellence southern catalonia, Avinguda Universitat, Catalonia, Spain
| | - Gerard Pujadas
- Grup de Recerca en Nutrigenòmica, Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Campus de Sescelades, Tarragona, Catalonia, Spain
- Centre Tecnològic de Nutrició i Salut, TECNIO, Campus of International excellence southern catalonia, Avinguda Universitat, Catalonia, Spain
- * E-mail:
| |
Collapse
|
8
|
Abe M, Nagai M, Yamamoto K, Yamazaki H, Koga I, Satoh Y, Muraoka Y, Kurashige S, Ichikawa YI. Development of a Large-Scale Synthesis of Sulphostin, a Dipeptidyl Peptidase IV Inhibitor. Org Process Res Dev 2005. [DOI: 10.1021/op058000c] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Masatoshi Abe
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Masashi Nagai
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Keiichiro Yamamoto
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Hiroko Yamazaki
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Ichiro Koga
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Yoshitaka Satoh
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Yasuhiko Muraoka
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Shuji Kurashige
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| | - Yuh-ichiro Ichikawa
- Research and Development Division, Pharmaceuticals Group, Nippon Kayaku Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-8588, Japan, Microbial Chemistry Research Center, 14-23, Kamiosaki 3-chome, Shinagawa-ku, Tokyo 141-0021, Japan, and Synthetic Group, NAC Co. Ltd., 31-12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan
| |
Collapse
|